Pesquisando por: ""cidade_pt:Leverkusen"" - Fotoarena - Agência de fotojornalismo

akg639321 Morellet, François ; né en 1926. "Trame sphérique", 1962. Acier, dm. 1,25. Museum: Leverkusen, Museum Morsbroich.

dpa7372197 (dpa) - A TV camera operator of the German pay TV channel Premiere World films a Bundesliga soccer game in the stadium in Leverkusen, Germany, 16 August 2003.

akg235704 Jawlensky, Alexej von Russian artist. 13.3.1864 - 15.3.1941. "Mystical head: John the Baptist", 1917. Oil on cardboard, 39 × 30.8 cm. Leverkusen, Museum Morsbroich. Museum: Leverkusen, Museum Morsbroich. Copyright: Additional copyrights may need to be cleared on this image when licensed for use by clients in the USA. Please contact us for additional information.

dpa7412485 (dpa) - Infant girl Laureta lies well cushioned in the Remigius hospital in Leverkusen, Germany, 7 May 2005. The four day old infant was found safe and sound after she was kidnapped on 4 May 2005.

dpa9036149 Employees of the Bayer Industry Services protest on reduction of jobs and reorganisation at the company's headquarters in Leverkusen, Germany, Tuesday, 24 October 2006. 600 of the 5,800 employees are to be laid off and 2,300 are to be transferred to other companies. Photo: Oliver Berg.

dpa8394326 Cycling pro Danilo Hondo stands with the start gun at the start of the 91th 'Rund um Koeln' cycle race in Leverkusen, Germany, Monday 17 April 2006. Following the International Cycling Union (UCI) due to a usance he did not comply with Hondo does not as was planned start in the race. After achieving an interim injunction of the highest canton court of Waadt against his doping ban the 32 year-old was supposed to start for the third divisionary Lamonta. Hondo now plans to start in the 'Niedersachsen' cycle race on Wednesday 19 April. Photo: Federico Gambarini.

dpa7359832 (dpa) - View of the new headquarters of Bayer AG, Leverkusen, Germany, 22 October 2002. The producer of chemicals and pharmaceuticals has invested about 50 million euros into the office building next to its old head office building which will be torn down. CEO Werner Wenning said the building was to express commitment to Germany and especially to North Rhine Westphalia. The modern and transparent tower has a low energy consumption.

dpa8334765 (File) - The picture dated 01 February 2005 shows the logo of Bayer, Leverkusen, Germany. According to reports of both companies on late Thursday, 23 March 2006, the corporate group and chemical big group Bayer Leverkusen surprisingly agreed on a merger. The head office of the new stock corporation called 'Bayer Schering Pharma' is to be sttled in Berlin, Germany. Photo: Oliver Berg.

dpa7361485 (dpa) - A view over the factory plant of the German chemical group Bayer AG in Leverkusen, Germany, 22 October 2002.

dpa7391612 (dpa) - An employee works at the Newco pharmaceutical factory, a subsidiary of the Bayer group, in Leverkusen, Germany, 3 March 2004. Bayer floated most of its industrial chemicals and polymers operations as a separate stock market-listed company under the working title 'New Co'.

dpa7386051 (dpa files) - A view of the illuminated Bayer cross, and the compound of the Bayer chemicals plant in Leverkusen, Germany, 11 March 2002. For the first time, Bayer is not liable to pay any business taxes this year.

dpa7409083 (dpa) - An employee takes colour pigments for the production of varnish from a filter press at the Newco pharmaceutical factory, a subsidiary of the Bayer group, in Leverkusen, Germany, 3 March 2004. Bayer floated most of its industrial chemicals and polymers operations as a separate stock market-listed company under the working title 'New Co'.

dpa7381792 (dpa) - The board of directors of Bayer AG, the German pharmaceutical group, sit in an auditorium in front of a crowd and speak during a balance press conference in Leverkusen, Germany, 13 March 2003. A weak world economy and rising oil prices had a negative effect on the balance of 2002. Bayer AG is pressured from all sides and fears to be sued for damages in the Lipobay process. However, there is cautious optimism in light of business development so far this year. Bayer expects growth in operating results in 2003.

dpa7385668 (dpa) - A view of the illuminated Bayer cross and the compound of the Bayer chemicals plant in Leverkusen, Germany, 21 October 2003.

dpa7377136 (dpa) - Bayer advertises the medicament Aspirin in Leverkusen, Germany, 13 March 2003. When exactly the pain killer was invented is not exactly known. The white powder was put on the market by Friedr. Bayer AG & Co. (today Farbenfabriken) 100 years ago. Today, each year 50,000t of Aspirin are produced worldwide. Bayer alone sells 11 million small white Aspirin pills in over 70 countries each year. However, a weak world economy and rising oil prices had a negative effect on Bayer's balance of 2002. Bayer AG is pressured from all sides and fears to be sued for damages in the Lipobay process. Still, there is cautious optimism in light of business development so far this year. Bayer expects growth in operating results in 2003.

dpa7372700 (dpa) - A freight ship passes the plant of the chemical and pharmaceutical group Bayer AG on the River Rhine in Leverkusen, Germany, 5 August 2003. Bayer on 6 August 2003 announced that it increased its results in the second quarter although it narrowly failed to meet expectations of analysts. In comparison to the previous year consolidated earnings before tax and interest rose 80.2 per cent to 454 million euros.

dpa9951820 (FILE) The undated handout computer montage shows the new logo of the Bayer AG, the so-called Bayer cross, at the headquarters of the group in Leverkusen, Germany. The Bayer AG states on 15 May 2007 that the 50-years-old 'Bayer cross' will get dismounted and in the future projected onto the 122 metres tall head office of the German chemical- and pharmaceutical group. State-of-the-art technology allows the around-the-clock projection of two 40 by 40 metres large crosses. With it Bayer decided against tearing-off its old group headquarters and for remodelling the empty administration building to a media cladding until spring 2009. Photo: Bayer AG.

dpa9786362 The lights of the Bayer main plant reflect in the river Rhine in Leverkusen, Germany, Sunday, 9 April 2007. Chemicals giant Bayer AG counts among the world's leading producers of pharmaceuticals and employs several thousand persons in its Leverkusen plant. Photo: Boris Roessler.

dpa9786370 The lights of the Bayer main plant reflect in the river Rhine in Leverkusen, Germany, Sunday, 9 April 2007. Chemicals giant Bayer AG counts among the world's leading producers of pharmaceuticals and employs several thousand persons in Leverkusen. Photo: Boris Roessler.

dpa9786346 The lights of the Bayer main plant reflect in the river Rhine in Leverkusen, Germany, Sunday, 9 April 2007. Chemicals giant Bayer AG counts among the world's leading producers of pharmaceuticals. Bayer employs several thousands in Leverkusen. Photo: Boris Roessler.

dpa7379930 (dpa files) - Crop seedlings are grown in petri dishes at the Bayer CropScience company, pictured on a company handout dated November 2002. Researchers examine the seedlings for their specific charasteristics as part of a phytosanitary research. The aim is to find means to repel varmints and diseases, while at the same time to protect other parts of the plants' biological system. (ATTENTION: Picture allowed for use only with copyright mention 'Photo: Bayer AG'!).

dpa7386171 (dpa) - A visitor (blurred) walks past the two artworks titled 'Marion Baronin Franchetti' (L) by Franz von Lenbach and 'Marilyn' by Andy Warhol which are exhibited at the Morsbroich museum in Leverkusen, Germany, 16 October 2003. The museum features the exhibition 'Die ganz moderne Kunst über den Haufen zu werfen - Franz von Lenbach und die Kunst von heute' (throwing over modern art - Franz von Lenbach and today's art) which will last from 19 October 2003 until 29 Ferbuary 2004. The exhibition includes around 80 portraits, still lives and landscape paintings of the renown painter Franz von Lenbach (1836-1904) as well as 40 works of modern artists in contrast.

dpa7377878 (dpa files) - Japanese conductor Eiji Oue conducts the Radio Philharmonie Hannover in Leverkusen, Germany, 26 October 1999. Born to a samurai family in Hiroshima, Japan, Eiji Oue started his musical education at age four. He later studied conducting at the Toho School of Music and at the New Engand Conservatory. From 1991 to 1995 Eiji Oue served as musical director at the Erie Philharmonic Orchestra, following a post in the same position at the Minnesota Orchestra, a post he held for seven years until July 2002. Since 1997 Eiji is also musical director of the Grand Teton Music Festival in Wyoming, and since the 1998/1999 season of the Radio Philharmonie Hannover of the German broadcasting station NDR. In May 2003 Eiji Oue is to give his debut as music director of the Osaka Philharmonic Orchestra.

dpa7378639 (dpa files) - German maestro Christoph Eschenbach conducts the NDR orchestra during a rehearsal for the Schleswig-Holstein Music Festival in Leverkusen, Germany, 23 September 1999. Eschenbach was born Christoph Ringmann on 20 February 1940 in Breslau, Germany (today Wroclaw, Poland). During the Second World War he lost his entire family, was adopted and later took on the surname of his adoptive parents. Eschenbach studied music and conducting in Bonn and Hamburg and became reputed both as a conductor and a concert pianist. He is currently Chief Conductor of the NDR Symphony in Hamburg, Music Director of the Orchestre de Paris, and Artistic Director of the Schleswig-Holstein Music Festival in Germany. In the United States, Eschenbach is Music Director of the Ravinia Festival, where he leads the Chicago Symphony Orchestra each summer in addition to appearing in chamber music performances, and is also Conductor Laureate of the Houston Symphony Orchestra, where he served as music director from 1988 to 1999. With the 2003-2004 concert season, beginning in September 2003, Eschenbach is to take up the position as Music Director of the Philadelphia Orchestra.

dpa7377285 (dpa files) - German maestro Christoph Eschenbach conducts the NDR orchestra during a rehearsal for the Schleswig-Holstein Music Festival in Leverkusen, Germany, 23 September 1999. Eschenbach was born Christoph Ringmann on 20 February 1940 in Breslau, Germany (today Wroclaw, Poland). During the Second World War he lost his entire family, was adopted and later took on the surname of his adoptive parents. Eschenbach studied music and conducting in Bonn and Hamburg and became reputed both as a conductor and a concert pianist. He is currently Chief Conductor of the NDR Symphony in Hamburg, Music Director of the Orchestre de Paris, and Artistic Director of the Schleswig-Holstein Music Festival in Germany. In the United States, Eschenbach is Music Director of the Ravinia Festival, where he leads the Chicago Symphony Orchestra each summer in addition to appearing in chamber music performances, and is also Conductor Laureate of the Houston Symphony Orchestra, where he served as music director from 1988 to 1999. With the 2003-2004 concert season, beginning in September 2003, Eschenbach is to take up the position as Music Director of the Philadelphia Orchestra.

dpa11132399 Jazz musician Klaus Doldinger plays the saxophone with his jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa11132307 Jazz musician Klaus Doldinger plays the saxophone with his jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa11132442 Jazz musician Klaus Doldinger (L) and pop singer Sasha perform with the jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa11132432 Jazz musician Klaus Doldinger plays the saxophone with his jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa13124258 Pianist Chick Corea (L) and guitarist John McLaughlin (R) perform together during the Jazz Days in Leverkusen, Germany, 06 November 2008. It is the first joined gig of Corea and McLaughlin in Germany since 40 years. The last occasion they played together was Miles Divis? ?Bitches Brew? production at the end of the sixties. Photo: Felix Heyder.

dpa7676163 (dpa) - Bayer chairman Werner Wenning and chief of finance Klaus Kuehn smiles prior to the company's autumn press conference in Leverkusen, Germany, Wednesday 09 November 2005. Chemical and pharmacy giant Bayer increased its profit in the third quarter. Profit increased up to 493 million euros in comparison to last year's 52 million euros. A special revenue of 179 million euros coming from changed pension contracts played the major role in the profit boost. Due to a solid chemical and pharmacy business sales increased by 19.1 percent up to 6.53 billion euros. Photo: Federico Gambarini.

dpa7361656 (dpa) - View of the new headquarters of Bayer AG, Leverkusen, Germany, 22 October 2002. The producer of chemicals and pharmaceuticals has invested about 50 million euros into the office building next to its old head office building which will be torn down. CEO Werner Wenning said the building was to express commitment to Germany and especially to North Rhine Westphalia. The modern and transparent tower has a low energy consumption.

dpa7361655 (dpa) - View of the new headquarters of Bayer AG, Leverkusen, Germany, 22 October 2002. The producer of chemicals and pharmaceuticals has invested about 50 million euros into the office building next to its old head office building which will be torn down. CEO Werner Wenning said the building was to express commitment to Germany and especially to North Rhine Westphalia. The modern and transparent building has a low energy consumption.

dpa7363748 (dpa) - Workers of the railway repair works sit around on chairs on their strike pickets while one has chained himself to his chair in Leverkusen-Opladen, western Germany, 27 June 2003. With a hunger strike they are protesting against the planned closing of the repair works of the German railroad corporation Deutsche Bahn. 430 workers are affected by the closing down with an additional 90 employees from other service departments.

dpa7372702 (dpa) - A freight ship passes the factory plant of the German chemical group Bayer AG in Leverkusen, Germany, 5 August 2003.

dpa7349319 (dpa) - Manfred Schneider (L), parting CEO of the German chemical group Bayer, and his successor, CFO Werner Wenning (R), present the annual results of 2001 on a press conference in Leverkusen, Germany, 13 March 2002. The pharmaceutical and chemical manufacturer that was facing severe problems with its cholesterol drug Lipobay is now listing on the American stock market.

dpa7381874 (dpa files) - Russian conductor and pianist Vladimir Ashkenazy conducts the Deutsche Symphonie Orchester in Leverkusen, Germany, January 1999. The first part of Ashkenazy's long career as a musician was devoted to the piano. He studies at the Central School of Music and at the Moscow Conservatoire and then spent three decades touring the great musical centres of the world, performing a recital and concerto repertoire. From the 1970s onwards, Ashkenazy became increasingly active as a conductor and held positions over the years with the Philharmonia Orchestra, the Royal Philharmonic Orchestra, the Cleveland Orchestra and the Deutsches Symphonie Orchester Berlin.

dpa7376919 (dpa) - The feet of ten members of the staff association of the railway repair works are tied together with chains, in Leverkusen-Opladen, western Germany, 8 May 2003. With a hunger strike they are protesting against the planned closing of the repair works of the German railroad corporation Deutsche Bahn.

dpa10507974 CEO of Bayer AG, Werner Wenning (L) greats German Environment Minister Sigmar Gabriel at the United Nations 'TUNZA International Youth Conference' in Leverkusen, Germany, 27 August 2007. 180 youths from 85 different nations take part in the five-day meeting. Photo: Oliver Berg.

dpa11622690 German long-jumper Nils Winter (R) and German triple-jumper Charles Fridek (L) pose on the premises of sports club Bayer 04 Leverkusen, Germany, 18 February 2008. The two of them aim to claim a starting lot for the 2008 Summer Olympics in Beijing, China, on their own account and thus founded their own club, the 'Team Referenznetzwerk Leverkusen'. Photo: JOERG CARSTENSEN.

dpa11622689 German long-jumper Nils Winter (R) and German triple-jumper Charles Fridek (L) pose on the premises of sports club Bayer 04 Leverkusen, Germany, 18 February 2008. The two of them aim to claim a starting lot for the 2008 Summer Olympics in Beijing, China, on their own account and thus founded their own club, the 'Team Referenznetzwerk Leverkusen'. Photo: JOERG CARSTENSEN.

dpa12829608 Fussball Champions League Saison 2002/2003 Patrick Kluivert, Einzelaktion am Ball FC Barcelona FOTO: ULMER/Bjoern Hake |.

dpa12829612 Fussball Champions League Saison 2002/2003 Xavi, Einzelaktion am Ball FC Barcelona FOTO: ULMER/Bjoern Hake |.

dpa11132300 German pop singer Sasha performs with Klaus Doldinger's jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa11132299 German pop singer Sasha performs with Klaus Doldinger's jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa11132290 German pop singer Sasha performs with Klaus Doldinger's jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa11132286 German pop singer Sasha performs with Klaus Doldinger's jazz band 'Passport' at the 28th Jazz Days in Leverkusen, Germany, 08 November 2007. Photo: Horst Ossinger.

dpa11114706 Bayer-CEO Werner Wenning presents business numbers in Leverkusen, Germany, 06 November 2007. The German chemical and pharmaceutical company heads for record result after three brilliant quarters. Until September the company's net gain climbed to 4.6 billion euros, also referable to capital profits and fiscal effects. Photo: OLICER BERG.

dpa11114037 Bayer-CEO Werner Wenning presents business numbers in Leverkusen, Germany, 06 November 2007. The German chemical and pharmaceutical company heads for record result after three brilliant quarters. Until September the company's net gain climbed to 4.6 billion euros, also referable to capital profits and fiscal effects. Photo: OLICER BERG.

dpa10836596 .jpg Sir Bobby ROBSON, England, Fussball, Trainer Newcastle United, Portraet, Qf Bayer Leverkusen - Newcastle United 1:3, Fussball Champions League am 18.02.2003.

dpa10507938 Director of UNEP (United Nations Environment Programme), Achim Steiner is pictured on the podium during the TUNZA International Youth Conference in Leverkusen, Germany, 27 August 2007. 180 youths from 85 different nations take part in the five-day meeting. Photo: Oliver Berg.

dpa9638001 Chemical and pharmaceuticals giant Bayer AG CEO Werner Wenning is pictured during the annual balance press conference in Leverkusen, Germany, Thursday, 15 March 2007. Thanks to stable business activities and the takeover of the Schering AG Bayer was able to increase its operational profit in 2006 distinctively. Photo: Oliver Berg.

dpa9638000 Chemical and pharmaceuticals giant Bayer AG CEO Werner Wenning is pictured during the annual balance press conference in Leverkusen, Germany, Thursday, 15 March 2007. Thanks to stable business activities and the takeover of the Schering AG Bayer was able to increase its operational profit in 2006 distinctively. Photo: Oliver Berg.

dpa9592132 The picture shows the plant of Bayer in Leverkusen, Germany, Friday, 02 March 2007. As Bayer announces, 1,500 German jobs will be cut for the merger of Bayer and Schering to the new leader in German pharmaceuticals market. Worldwide, a total of 6,100 jobs are laid-off. Photo: Oliver Berg.

dpa9143078 CEO of Bayer AG Werner Wenning gestures at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann.

dpa9142634 Bayer AG CEO Werner Wenning smiles at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann.

dpa9142633 Bayer AG CEO Werner Wenning arrives at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann.

dpa9142628 Bayer AG CEO Werner Wenning smiles at his company's autumn press conference in Leverkusen, Germany, Monday, 27 November 2006. Third-quarter sales increase by 26 percent to 7.783 billion euro. The acquisition of Schering pushed the good results. Photo: Achim Scheidemann.

dpa7676177 (dpa) - Bayer chairman Werner Wenning smiles lightly during the company's autumn press conference in Leverkusen, Germany, Wednesday 09 November 2005. Chemical and pharmacy giant Bayer increased its profit in the third quarter. Profit increased up to 493 million euros in comparison to last year's 52 million euros. A special revenue of 179 million euros coming from changed pension contracts played the major role in the profit boost. Due to a solid chemical and pharmacy business sales increased by 19.1 percent up to 6.53 billion euros. Photo: Federico Gambarini.

dpa7409232 (dpa) - Werner Wenning, chairman of Bayer AG, stands in front of the company's logo and speaks during the balance press conference in Leverkusen, Germany, 18 March 2004. The pharmaceuticals and chemicals company Bayer has registered a loss of 1,4 billion euros due to the high amortisations in the 2003 business year. The company had achieved a surplus of 1,1 billion euros in 2002. However, Bayer announced the business operations have improved significantly. Overall the company registered an operative business result in the amount of 1,4 billion euros before untaxed special reserve, which reflects a 67 percent higher business result for 2003 in comparison to the 2002 business year.

dpa7409231 (dpa) - Werner Wenning, chairman of Bayer AG, stands in front of the company's logo and smiles during the balance press conference in Leverkusen, Germany, 18 March 2004. The pharmaceuticals and chemicals company Bayer has registered a loss of 1,4 billion euros due to the high amortisations in the 2003 business year. The company had achieved a surplus of 1,1 billion euros in 2002. However, Bayer announced the business operations have improved significantly. Overall the company registered an operative business result in the amount of 1,4 billion euros before untaxed special reserve, which reflects a 67 percent higher business result for 2003 in comparison to the 2002 business year.

dpa7409230 (dpa) - Werner Wenning, chairman of Bayer AG, looks concentrated during the balance press conference in Leverkusen, Germany, 18 March 2004. The pharmaceuticals and chemicals company Bayer has registered a loss of 1,4 billion euros due to the high amortisations in the 2003 business year. The company had achieved a surplus of 1,1 billion euros in 2002. However, Bayer announced the business operations have improved significantly. Overall the company registered an operative business result in the amount of 1,4 billion euros before untaxed special reserve, which reflects a 67 percent higher business result for 2003 in comparison to the 2002 business year.

dpa7409122 (dpa) - Packs of Levitra anti-impotence pills are seen at the factory of German chemical and pharmaceutical group Bayer in Leverkusen, Germany, 3 March 2004. Bayer announced its 2003 figures on 18 March 2004. The day before Levitra was approved in Canada.

dpa7409121 (dpa) - An employee oversees the packaging of the anti-impotence pills Levitra, at the factory of German chemical and pharmaceutical group Bayer in Leverkusen, Germany, 4 March 2004. Bayer announced its 2003 figures on 18 March 2004. The day before Levitra was approved in Canada.

dpa7404732 (dpa) - Pianist Nicholas Angelich plays the piano during a rehearsal for a Liszt soiree in Leverkusen, Germany, 19 September 2003. Angelich, a specialist for classical music and romanticism, was born in the United States and lives in Paris.

dpa7396743 (dpa) The new head coach of the German national soccer team Juergen Klinsmann (right) and the former national coach Rudi Voeller are observing the premier league match between Bayer 04 Leverkusen and Hannover 96 in the Leverkusen BayArena on 07 August 2004. Leverkusen won 2:1.

dpa7385235 (dpa) - Werner Wenning, CEO of the German pharmaceutical group Bayer, attends a press conference in Leverkusen, Germany, 11 November 2003. Bayer AG, a world leader in the production of pharmaceuticals and chemicals, said it lost money in the third quarter despite a strong rise in operating results. The net loss in the 3rd quarter was totalling 123 million euros. The red ink was attributed to a poor economy, restructuring costs and write-offs in plant protection chemicals.

dpa7385234 (dpa) - Claus Heitmann, the designated CEO of the 'NewCo', pictured during a press conference of the pharmaceutical group Bayer in Leverkusen, Germany, 11 November 2003. Last week, Bayer announced plans to float most of its industrial chemicals and polymers operations as a separate stock market-listed company under the working title 'New Co'. It is not yet decided if the new company will be listed individually on the stock market or if the shareholders of Bayer will receive shares of the new corporation.

dpa7381877 (dpa files) - Russian conductor and pianist Vladimir Ashkenazy conducts the Deutsche Symphonie Orchester in Leverkusen, Germany, January 1999. The first part of Ashkenazy's long career as a musician was devoted to the piano. He studies at the Central School of Music and at the Moscow Conservatoire and then spent three decades touring the great musical centres of the world, performing a recital and concerto repertoire. From the 1970s onwards, Ashkenazy became increasingly active as a conductor and held positions over the years with the Philharmonia Orchestra, the Royal Philharmonic Orchestra, the Cleveland Orchestra and the Deutsches Symphonie Orchester Berlin.

dpa7381875 (dpa files) - Russian conductor and pianist Vladimir Ashkenazy conducts the Deutsche Symphonie Orchester in Leverkusen, Germany, January 1999. The first part of Ashkenazy's long career as a musician was devoted to the piano. He studies at the Central School of Music and at the Moscow Conservatoire and then spent three decades touring the great musical centres of the world, performing a recital and concerto repertoire. From the 1970s onwards, Ashkenazy became increasingly active as a conductor and held positions over the years with the Philharmonia Orchestra, the Royal Philharmonic Orchestra, the Cleveland Orchestra and the Deutsches Symphonie Orchester Berlin.

dpa7381842 (dpa) - Werner Wenning, CFO of the German chemical group Bayer and designated CEO, straightens his tie and presents the annual results of 2001 on a press conference in Leverkusen, Germany, 13 March 2002. The pharmaceutical and chemical manufacturer that was facing severe problems with its cholesterol drug Lipobay is now listing on the American stock market.

dpa7381791 (dpa) - Werner Wenning, CEO of Bayer AG, the German pharmaceutical group, speaks and answers questions during a balance press conference in Leverkusen, Germany, 13 March 2003. A weak world economy and rising oil prices had a negative effect on the balance of 2002. Bayer AG is pressured from all sides and fears to be sued for damages in the Lipobay process. However, there is cautious optimism in light of business development so far this year. Bayer expects growth in operating results in 2003.

dpa7381760 (dpa) - A cleaner wipes the logo of the pharmaceutical group Bayer prior to a balance press conference in Leverkusen, Germany, 13 March 2003. A weak world economy and rising oil prices had a negative effect on the balance of 2002. Bayer AG is pressured from all sides and fears to be sued for damages in the Lipobay process. However, there is cautious optimism in light of business development so far this year. Bayer expects growth in operating results in 2003.

dpa7379823 (dpa) - German cyclist Jan Ullrich of Team Coast happily wins the Tour of Cologne, Germany, 21 April 2003. Ullrich claimed his first victory in 18 months after leaving the field in his trail to win the 88th Tour of Cologne. Ullrich, the 29-year-old Olympic champion and the only German to have won the Tour de France (1997), recently returned from a long lay-off due to a drugs ban and undergoing operations on a troublesome knee.

dpa7377017 (dpa) - Werner Wenning, CEO of the German chemical group Bayer, gestures during a press conference in Leverkusen, Germany, 13 March 2002. Bayer is facing severe problems with its cholesterol drug Lipobay (or Baycol) which was withdrawn on and a half years ago after a number of deaths were linked to it. Bayer AG is pressured from all sides and fears to be sued for damages in the Lipobay process. However, there is cautious optimism in light of business development so far this year. Bayer expects a growth in operating results in 2003.

dpa7372196 (dpa) - A TV camera operator of the German pay TV channel Premiere World films a Bundesliga soccer game in the stadium in Leverkusen, Germany, 16 August 2003.

dpa7367512 (dpa files) - A laboratory worker handles a system for process development and optimisation of pharmaceuticals, fine chemicals and biological products at a laboratory of the pilot plant station of Bayer Chemicals, a subsidiary of the German chemical group Bayer AG, in Leverkusen, Germany, November 2002. Bayer Chemicals, which has about 14,500 employees, was formed during a reorganization of the Bayer group in 2002. (ATTENTION: Picture allowed for use only with copyright mention 'Photo: Bayer AG'!).

dpa7354940 (dpa) - German conductor Gerd Albrecht rehearses with the Cologne Philharmonic Orchestra in Leverkusen, Germany, 4 December 2002.

dpa7349321 (dpa) - Werner Wenning, CFO of the German chemical group Bayer and designated CEO, presents the annual results of 2001 on a press conference in Leverkusen, Germany, 13 March 2002. The pharmaceutical and chemical manufacturer that was facing severe problems with its cholesterol drug Lipobay is now listing on the American stock market.

dpa7349318 (dpa) - Werner Wenning, CFO of the German chemical group Bayer and designated CEO, presents the annual results of 2001 on a press conference in Leverkusen, Germany, 13 March 2002. The pharmaceutical and chemical manufacturer that was facing severe problems with its cholesterol drug Lipobay is now listing on the American stock market.

dpa7348081 (dpa) - Werner Wenning, CFO of the German chemical group Bayer and designated CEO, presents the annual results of 2001 on a press conference in Leverkusen, Germany, 13 March 2002. The pharmaceutical and chemical manufacturer that was facing severe problems with its cholesterol drug Lipobay is now listing on the American stock market.

dpa7348079 (dpa) - The Bayer logo, reaching 120 metres in height and illuminated by 1700 light bulbs, rises high over the company's headquarters in Leverkusen, Germany, 11 March 2002. The pharmaceutical and chemical manufacturer that was facing severe problems with its cholesterol drug Lipobay is now listing on the American stock market.